Bernd Kuntscher
Bernd holds a Master of Science in Economics from the Stockholm School of Economics and has over 30 years of experience in pharmaceuticals and medical technology from companies such as AstraZeneca, Q-MED, Navigare, Schwarz Pharma and Orphan Europe/Recordati Rare Diseases. Bernd has worked both Nordic and international in senior positions in both sales and marketing and corporate management. The last 15 years in the area of orphan drugs, primarily for metabolic and endocrinological diseases. During these years, Bernd has acquired extensive experience in product launches, market planning, sales management, market access and general corporate management. Bernd’s main focus is to help companies that are in an early stage, preferably in diagnostics or rare diseases.
